Seagen Shareholders Approve Pfizer's Acquisition Deal
May 30 2023 - 4:15PM
Dow Jones News
By Sabela Ojea
Seagen said Tuesday its shareholders voted in favor of Pfizer
buying the company for $43 billion.
The biotechnology cancer specialist continues to expect to close
the deal in late 2023 or early 2024 amid pending regulatory
approvals.
In March, Pfizer said it entered into a definitive merger
agreement with Seagen for $299 per share in cash to invest in
cancer treatments.
The boards of directors of both parties back the
transaction.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
May 30, 2023 16:00 ET (20:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024